Thienopyridone derivatives as AMPactivated protein kinase (AMPK) activators

Details for Australian Patent Application No. 2009235784 (hide)

Owner Merck Patent GmbH

Inventors Hallakou-Bozec, Sophie; Lepifre, Franck; Charon, Christine; Cravo, Daniel

Agent Davies Collison Cave

Pub. Number AU-A-2009235784

PCT Pub. Number WO2009/124636

Priority 08290364.2 11.04.08 EP

Filing date 17 March 2009

Wipo publication date 15 October 2009

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/4365 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 December 2010 PCT application entered the National Phase

  PCT publication WO2009/124636 Priority application(s): WO2009/124636

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009235786-Glucopyranoside derivatives

2009235761-Arrangement of a bellow on a guide mandrel of a disc brake